Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 0.111 Q4 | 9 | 2 | 3 | 348 | 0 | 3 | 0.00 | 174.00 | 63.24 | |
2 | Advances in Cancer Research | journal | 109 | 39 | 116 | 6199 | 759 | 0 | 6.60 | 158.95 | 55.56 | ||
3 | MedComm | journal | 1.926 Q1 | 25 | 223 | 171 | 32320 | 1408 | 145 | 9.20 | 144.93 | 41.88 | |
4 | Annual Review of Cancer Biology | book series | 3.766 Q1 | 36 | 18 | 61 | 2133 | 423 | 61 | 5.00 | 118.50 | 38.18 | |
5 | Blood Reviews | journal | 2.216 Q1 | 112 | 82 | 202 | 9639 | 1470 | 201 | 7.19 | 117.55 | 37.56 | |
6 | Ca-A Cancer Journal for Clinicians | journal | 106.094 Q1 | 211 | 49 | 124 | 4844 | 35427 | 89 | 381.89 | 98.86 | 43.95 | |
7 | NTP Technical Report on the Toxicity Studies Series | book series | 0.110 Q4 | 6 | 2 | 10 | 191 | 2 | 9 | 0.14 | 95.50 | 50.00 | |
8 | National Toxicology Program technical report series | journal | 0.111 Q4 | 22 | 2 | 5 | 185 | 1 | 5 | 0.00 | 92.50 | 0.00 | |
9 | Drug Resistance Updates | journal | 4.665 Q1 | 132 | 74 | 76 | 6493 | 1477 | 75 | 17.53 | 87.74 | 34.58 | |
10 | Hepatoma Research | journal | 0.417 Q3 | 14 | 48 | 202 | 3901 | 295 | 189 | 1.55 | 81.27 | 50.00 | |
11 | Current Treatment Options in Oncology | journal | 1.326 Q1 | 66 | 115 | 332 | 8845 | 1403 | 327 | 3.91 | 76.91 | 45.88 | |
12 | Journal of Cancer Metastasis and Treatment | journal | 0.485 Q3 | 16 | 34 | 172 | 2569 | 299 | 163 | 1.58 | 75.56 | 36.54 | |
13 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.964 Q2 | 112 | 24 | 80 | 1765 | 228 | 75 | 2.77 | 73.54 | 49.15 | |
14 | Current Hematologic Malignancy Reports | journal | 0.998 Q2 | 44 | 31 | 130 | 2271 | 402 | 130 | 2.83 | 73.26 | 46.74 | |
15 | Immuno-Oncology and Technology | journal | 1.987 Q1 | 10 | 15 | 28 | 1090 | 108 | 23 | 4.82 | 72.67 | 48.35 | |
16 | Current Oncology Reports | journal | 1.498 Q1 | 77 | 132 | 445 | 9478 | 2209 | 441 | 4.93 | 71.80 | 42.58 | |
17 | Trends in Cancer | journal | 4.513 Q1 | 90 | 111 | 338 | 7747 | 3828 | 324 | 9.71 | 69.79 | 40.00 | |
18 | Seminars in Radiation Oncology | journal | 1.038 Q2 | 103 | 46 | 134 | 3187 | 426 | 124 | 2.68 | 69.28 | 40.72 | |
19 | Cancer journal (Sudbury, Mass.) | journal | 0.933 Q2 | 102 | 55 | 218 | 3810 | 493 | 200 | 2.51 | 69.27 | 38.30 | |
20 | Medical Oncology | journal | 0.763 Q2 | 90 | 359 | 520 | 23351 | 1600 | 500 | 3.02 | 65.04 | 40.77 | |
21 | Trends in Immunotherapy | journal | 0.133 Q4 | 4 | 28 | 54 | 1817 | 14 | 51 | 0.24 | 64.89 | 37.86 | |
22 | Cancer Cell | journal | 17.507 Q1 | 398 | 178 | 590 | 11546 | 12604 | 360 | 19.83 | 64.87 | 41.91 | |
23 | Current Breast Cancer Reports | journal | 0.351 Q3 | 24 | 44 | 122 | 2734 | 138 | 121 | 1.10 | 62.14 | 61.18 | |
24 | Therapeutic Advances in Medical Oncology | journal | 1.529 Q1 | 68 | 175 | 571 | 10526 | 2480 | 559 | 4.06 | 60.15 | 44.46 | |
25 | Hematology/Oncology Clinics of North America | journal | 0.705 Q2 | 95 | 93 | 275 | 5592 | 553 | 238 | 2.29 | 60.13 | 44.02 | |
26 | Current Opinion in HIV and AIDS | journal | 1.504 Q1 | 78 | 54 | 152 | 3140 | 597 | 136 | 3.96 | 58.15 | 44.44 | |
27 | Cancer Nanotechnology | journal | 0.671 Q3 | 36 | 83 | 90 | 4754 | 399 | 89 | 4.21 | 57.28 | 49.37 | |
28 | Oncology Research | journal | 0.472 Q3 | 76 | 70 | 174 | 3993 | 354 | 165 | 1.40 | 57.04 | 45.85 | |
29 | World Journal of Gastrointestinal Oncology | journal | 0.749 Q2 | 42 | 167 | 456 | 9461 | 1249 | 455 | 2.40 | 56.65 | 39.37 | |
30 | Surgical Oncology Clinics of North America | journal | 0.642 Q3 | 68 | 63 | 180 | 3497 | 338 | 144 | 2.09 | 55.51 | 50.68 | |
31 | Molecular Cancer Research | journal | 1.660 Q1 | 153 | 108 | 490 | 5915 | 2237 | 483 | 3.88 | 54.77 | 40.15 | |
32 | Cancer Innovation | journal | 0.389 Q3 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | 41.16 | |
33 | Nutrition and Cancer | journal | 0.627 Q3 | 130 | 141 | 787 | 7553 | 2249 | 777 | 2.47 | 53.57 | 49.07 | |
34 | Current Opinion in Oncology | journal | 0.990 Q2 | 104 | 85 | 290 | 4473 | 919 | 267 | 2.68 | 52.62 | 44.00 | |
35 | Current Problems in Cancer | journal | 0.759 Q2 | 47 | 50 | 226 | 2582 | 551 | 216 | 2.48 | 51.64 | 51.07 | |
36 | Translational Oncology | journal | 1.263 Q1 | 72 | 231 | 831 | 11856 | 3891 | 812 | 4.53 | 51.32 | 41.85 | |
37 | Technology in Cancer Research and Treatment | journal | 0.609 Q3 | 72 | 230 | 815 | 11793 | 2100 | 809 | 2.51 | 51.27 | 44.59 | |
38 | Cytotherapy | journal | 1.084 Q2 | 105 | 155 | 345 | 7941 | 1252 | 327 | 3.60 | 51.23 | 43.81 | |
39 | Journal of Cancer Survivorship | journal | 1.201 Q1 | 81 | 318 | 347 | 15964 | 1453 | 342 | 3.87 | 50.20 | 66.90 | |
40 | Molecular Cancer Therapeutics | journal | 2.270 Q1 | 199 | 113 | 644 | 5528 | 3324 | 631 | 5.03 | 48.92 | 40.46 | |
41 | Seminars in Oncology | journal | 1.032 Q2 | 145 | 22 | 145 | 1054 | 488 | 138 | 2.71 | 47.91 | 45.52 | |
42 | Cancer Control | journal | 0.698 Q2 | 80 | 134 | 440 | 6091 | 1085 | 428 | 2.39 | 45.46 | 48.71 | |
43 | International Journal of Cancer | journal | 2.131 Q1 | 260 | 429 | 1584 | 19420 | 9422 | 1500 | 6.08 | 45.27 | 45.98 | |
44 | Molecular Imaging and Biology | journal | 0.752 Q2 | 78 | 125 | 364 | 5604 | 999 | 346 | 2.79 | 44.83 | 38.09 | |
45 | Cancer Biology and Therapy | journal | 0.914 Q2 | 130 | 83 | 267 | 3691 | 956 | 263 | 4.32 | 44.47 | 45.15 | |
46 | Current Opinion in Supportive and Palliative Care | journal | 0.733 Q2 | 50 | 49 | 131 | 2167 | 232 | 109 | 1.45 | 44.22 | 41.51 | |
47 | Cancer Investigation | journal | 0.604 Q3 | 93 | 83 | 247 | 3668 | 452 | 229 | 1.77 | 44.19 | 39.25 | |
48 | Integrative Cancer Therapies | journal | 0.687 Q3 | 71 | 95 | 328 | 4195 | 969 | 311 | 2.68 | 44.16 | 54.50 | |
49 | Sarcoma | journal | 0.545 Q3 | 53 | 4 | 75 | 176 | 157 | 75 | 1.44 | 44.00 | 19.51 | |
50 | Journal of Immunotherapy and Precision Oncology | journal | 0.668 Q3 | 9 | 24 | 83 | 1050 | 117 | 63 | 1.85 | 43.75 | 37.40 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®